NRC Health (NRC) stock
NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3081% above fair value
$26.56−0.08 (-0.30%)
Close on Nov 13, 2026Market cap $587.50MP/E –Yield 1.96%
NRC Health profit margin
Profit margin (net margin) is net income as a percentage of revenue.
NRC Health's profit margin for the twelve months ending Dec 31, 2018 was 25.1%. For fiscal 2018 it was 25.1%, against 19.5% the year before. The highest annual figure on record is 25.1% in fiscal 2018.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | 25.1% | +5.6 |
| FY2017 | Dec 31, 2017 | 19.5% | +0.8 |
| FY2016 | Dec 31, 2016 | 18.8% | +1.6 |
| FY2015 | Dec 31, 2015 | 17.2% | −1.2 |
| FY2014 | Dec 31, 2014 | 18.4% | +1.6 |
| FY2013 | Dec 31, 2013 | 16.7% | −0.7 |
| FY2012 | Dec 31, 2012 | 17.4% | +2.2 |
| FY2011 | Dec 31, 2011 | 15.3% | −3.0 |
| FY2010 | Dec 31, 2010 | 18.2% | +3.5 |
| FY2009 | Dec 31, 2009 | 14.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 12.3% | +12.6 |
| Q2 FY2026 | Jun 30, 2026 | -9.3% | −26.5 |
| Q1 FY2026 | Mar 31, 2026 | 9.3% | −16.2 |
| Q3 FY2025 | Sep 30, 2025 | 11.9% | −11.4 |
| Q2 FY2025 | Jun 30, 2025 | -0.3% | −28.7 |
| Q1 FY2025 | Mar 31, 2025 | 17.2% | −6.3 |
| Q4 FY2018 | Dec 31, 2018 | 25.5% | +3.7 |
| Q3 FY2018 | Sep 30, 2018 | 23.3% | +9.0 |
| Q2 FY2018 | Jun 30, 2018 | 28.4% | +8.1 |
| Q1 FY2018 | Mar 31, 2018 | 23.6% | +2.0 |
| Q4 FY2017 | Dec 31, 2017 | 21.8% | +1.6 |
| Q3 FY2017 | Sep 30, 2017 | 14.3% | – |
| Q2 FY2017 | Jun 30, 2017 | 20.2% | – |
| Q1 FY2017 | Mar 31, 2017 | 21.5% | – |
| Q4 FY2016 | Dec 31, 2016 | 20.2% | – |
See a number that looks wrong?